Masahiro Sekiguchi

9PUBLICATIONS
62CO-AUTHORS
Molecular targetsHaematological tumoursGene expression (incl. microarray and other genome-wide approaches)Gene and molecular therapyAdolescent health
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Apr 15, 2024
Inhibition of the galactosyltransferase C1GALT1 reduces osteosarcoma cell proliferation by interfering with ERK signaling and cell cycle progression.

Kentaro Watanabe, Keiji Tasaka, Hideto Ogata

|Apr 08, 2024
Single-cell multiomics reveals the interplay of clonal evolution and cellular plasticity in hepatoblastoma.

Amélie Roehrig, Theo Z Hirsch, Aurore Pire

|Nov 02, 2022
Identification of the ultrahigh-risk subgroup in neuroblastoma cases through DNA methylation analysis and its treatment exploiting cancer metabolism.

Kentaro Watanabe, Shunsuke Kimura, Masafumi Seki

|Aug 30, 2022
Multi-omics analysis defines highly refractory RAS burdened immature subgroup of infant acute lymphoblastic leukemia.

Tomoya Isobe, Masatoshi Takagi, Aiko Sato-Otsubo

|Apr 12, 2022
Novel TENM3-ALK fusion is an alternate mechanism for ALK activation in neuroblastoma.

Mitsuteru Hiwatari, Masafumi Seki, Ryosuke Matsuno

|Sep 06, 2021
COVID-19 in an adolescent with aplastic anemia undergoing immunosuppressive therapy: A case report and details of antibody testing for SARS-CoV-2.

Shota Kato, Yoshiko Nakano, Yuki Nakano

Pageof 2

Frequent Collaborators

7 joint publications

Junko Takita

5 joint publications

Kentaro Watanabe

4 joint publications

Masafumi Seki

4 joint publications

Tomoya Isobe